venetoclax,ibrutinib
janssen,abbvie,roche
['venetoclax', 'ibru', 'cll', 'leukemia', 'lymphoma']
#asco22: dr. rajat bannerji &amp; colleagues present fixed-duration (fd) ibrutinib (i) + venetoclax (v) for first-line (1l) treatment (tx) of chronic lymphocytic #leukemia (cll)/small lymphocytic #lymphoma (sll)... 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.